Trial Information

Summary: A placebo-controlled safety study to evaluate the cognitive effects of an investigational drug as add-on treatment in children 4-16 years old with refractory partial onset seizures.

We are currently conducting a research study for children with partial onset seizures not controlled adequately by their current medications. This study is testing an investigational drug as an add-on anti-epileptic medication to determine how the drug affects memory, learning, attention, behavior and quality of life in children. If your child is between the ages of 4 and 16 years old with a confirmed diagnosis of epilepsy for at least six months, he or she may be eligible for a research study.

To be eligible to participate, you must:

• Be 4-16 years of age
• Must be on a stable dose of one or no more than two other anti-epileptic medications
• The current medications are determined to be unsatisfactory in terms of efficacy in adequately controlling the seizures and alternative treatment with the study medication would be beneficial
• Weigh <= 36 lbs.

All study related clinic visits, testing, and study medications are provided at no cost. Compensation is provided.

If you would like to learn more about participating in this study, please send an e-mail message using the form below.